BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Quercetin
,
rs2476601
,
LEP
,
calcium channel activity
,
Arthritis
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cyclic depsipeptide
Summary
General Info
Curated Studies
Most Correlated Studies
Pancreatic duct cancer PANC-1 cells treated under hypoxia with rakicidin A and BE-43547
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Peripheral blood mononuclear cells of cutaneous T-cell lymphoma patients treated with romidepsin
Explore Curated Studies Results
Literature
Most Relevant Literature
Macrocyclization strategies for the total synthesis of cyclic depsipeptides.
Bioactive Piperazic Acid-Bearing Cyclodepsipeptides, Lydiamycins E-H, from an Endophytic Streptomyce…
Cytotoxic Cyclodepsipeptides and Cyclopentane Derivatives from a Plant-Associated Fungus Fusarium sp…
From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-…
Solonamides, a Group of Cyclodepsipeptides, Influence Motility in the Native Producer Photobacterium…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Emodepside Phase II Trial for Treatment of Onchocerciasis
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refract…
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Li…
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ